Quest Diagnostics (DGX) CEO Davis J. E. Sells 10,000 Shares

What Happened
Davis J. E., CEO, President and Director of Quest Diagnostics (DGX), disposed of 10,000 shares in an open-market sale on September 1, 2026 at $242.72 per share, for a total of $2,427,200. This was a sale (not a purchase).

Key Details

• Transaction date: 2026-09-01
• Price per share: $242.72; Total value: $2,427,200
• Transaction type/code: Open market sale (S) of 10,000 shares
• Footnote: Sale effected pursuant to a Rule 10b5-1 sales plan (prearranged plan)
• Filing: Form 4 filed 2026-09-03 (appears timely within standard Form 4 reporting window)
• Shares owned after transaction: Not specified in the provided filing excerpt (see full Form 4 for post-transaction beneficial ownership)

Context
A Rule 10b5-1 plan indicates the sale was prearranged and is often used to execute trades on a set schedule, which can make the transaction more routine and less indicative of new insider sentiment. In general, insider sales are common and less informative than purchases; review the full filing for ownership details and any additional disclosures.